Sequoia Pharmaceuticals
Sequoia Pharmaceuticals is a privately held Warsaw-based pharmaceutical company founded in 2008 that develops and manages pharmaceutical products, operating with a 101-250 employee headcount. Specific product, customer, and revenue disclosures are not available in the source data.
- Company typePrivate
- Founded2008
- HeadquartersWarsaw, Poland
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Sequoia Pharmaceuticals firmographics
Firmographics- Name
- Sequoia Pharmaceuticals
- Website
- https://sequoia.pl
- Company type
- Private
- Founded year
- 2008
- Headcount range
- 101–250 employees
- Short description
- Sequoia Pharmaceuticals is a privately held Warsaw-based pharmaceutical company founded in 2008 that develops and manages pharmaceutical products, operating with a 101-250 employee headcount. Specific product, customer, and revenue disclosures are not available in the source data.
- Ownership category
- akta.pro rank
Where Sequoia Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Warsaw
- HQ country
- Poland
- HQ region
- Europe
Markets served
Sequoia Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D
Sequoia Pharmaceuticals product offering
Product offeringCore offering
Sequoia Pharmaceuticals develops and manages pharmaceutical products. The company operates as a privately held pharmaceutical firm headquartered in Warsaw, Poland, founded in 2008, with a workforce of 101–250 employees. Beyond this general description, no specific product lines, therapeutic areas, dosage forms, or commercialized drugs are documented in the available sources.
Differentiator
Problem solved
Functional benefit
Companies that use Sequoia Pharmaceuticals
Customer profileIdeal customer profiles1 record
Sequoia Pharmaceuticals technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Sequoia Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sequoia Project Pharmacy Interoperability WorkgroupcoreSequoia Project Pharmacy Interoperability Workgroup collaborates with NCPDP on developing standards and implementation guides supporting care coordination and pharmacy interoperability. This workgroup is part of NCPDP's collaborative initiatives with external organizations to advance pharmacy interoperability standards heading into 2025.
Sequoia Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Krka: Slovenian generic pharmaceutical manufacturer with strong CEE and CIS market presence. Comparable to Sequoia Pharmaceuticals as an established Central European pharma developer with a focus on generic and specialty pharmaceutical products.
- Polpharma: Poland's largest pharmaceutical manufacturer and one of the leading generic drug producers in Central Europe. Directly comparable to Sequoia Pharmaceuticals as a Poland-based pharma operator producing and managing medicinal products across multiple therapeutic categories.
- Egis Pharmaceuticals: Hungarian pharmaceutical manufacturer producing generic, branded, and OTC medicines with significant CEE distribution. Comparable to Sequoia Pharmaceuticals as a Central European pharma developer with established product portfolio and regional reach.
- Adamed Pharma: Polish pharmaceutical and biotech company developing, manufacturing, and marketing both branded and generic drugs. Directly comparable to Sequoia Pharmaceuticals as a Warsaw-based pharma business with full development-to-commercialization capabilities.
- Gedeon Richter: Hungarian-headquartered pharmaceutical company with a broad portfolio in generic and specialty drugs, women's health, and biosimilars. Comparable as a Central European pharma manufacturer and brand owner with multi-decade operating history.
- Zentiva: A major European generics pharmaceutical company headquartered in Prague with significant manufacturing presence across Central and Eastern Europe. Comparable as a CEE-based pharmaceutical developer/manager operating at scale across generics and specialty pharma.
Regional players
- Celon Pharma: Polish pharmaceutical company focused on developing and manufacturing generic drugs and specialty pharma products. Comparable to Sequoia Pharmaceuticals as a Poland-based pharma operator, with similar therapeutic and regional focus areas.
Broad incumbents
- Sandoz: Global leader in generic and biosimilar medicines spun off from Novartis. Comparable to Sequoia Pharmaceuticals as a pharmaceutical products developer/manufacturer, though operating at significantly greater scale and geographic scope.
- Viatris: Global pharmaceutical company formed from the combination of Mylan and Upjohn, focused on generics, branded, and biosimilar medicines. Comparable as a broad pharma operator managing large portfolios of established pharmaceutical products across many markets.
- Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with operations across all major geographies. Broadly comparable to Sequoia Pharmaceuticals as a generic and specialty pharma operator, though vastly larger and globally diversified.
Market position
Customer concentration
Sequoia Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sequoia Pharmaceuticals leadership team
Management profileNumber of profiles
Sequoia Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sequoia Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sequoia Pharmaceuticals
What does Sequoia Pharmaceuticals do?
Sequoia Pharmaceuticals develops and manages pharmaceutical products. The company operates as a privately held pharmaceutical firm headquartered in Warsaw, Poland, founded in 2008, with a workforce of 101–250 employees. Beyond this general description, no specific product lines, therapeutic areas, dosage forms, or commercialized drugs are documented in the available sources.
When was Sequoia Pharmaceuticals founded?
Sequoia Pharmaceuticals was founded in 2008. It employs 101 to 250 people.
Where is Sequoia Pharmaceuticals based?
Sequoia Pharmaceuticals is headquartered in Warsaw, Poland, in the Europe region.
Who are Sequoia Pharmaceuticals's main competitors?
Direct peers on record are Krka, Polpharma, Egis Pharmaceuticals, Adamed Pharma, Gedeon Richter and Zentiva. Celon Pharma is listed as a regional player. Broad incumbents are Sandoz, Viatris and Teva Pharmaceutical Industries.
Does Sequoia Pharmaceuticals have an API?
No public API is recorded for Sequoia Pharmaceuticals.